FOLD
Amicus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.49
+0.00%Aug 12, 2026, 14:05 UTC
BioMarin Pharmaceutical announced plans to integrate Amicus Therapeutics as part of its rare-disease growth strategy, with a focus on faster deleveraging.
Source: